NCT05496231 2025-02-03A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of AgeGlaxoSmithKlinePhase 1/2 Completed1,080 enrolled 28 charts
NCT03051516 2024-02-28HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal LesionsFred Hutchinson Cancer CenterPhase 4 Terminated188 enrolled 13 charts